The system earned FDA clearance in October and made its debut in April. The system is designed for SI joint fusion when treating sacroiliac joint disruptions, degenerative sacroiliitis and other conditions. It has a Transfixing-Cone, an ilium screw, a sacrum screw and associated instruments.
“The release of SiLO TFX is proceeding smoothly and rapidly as we deploy more instruments sets and implants into the field,” Petra Lopizzo, Aurora Spine’s director of operations, said in the release.
